Skip to main content

Table 7 Assay of GLM marketed tablets Amaryl® ( n= 3)

From: Development and validation of RP-HPLC method for glimepiride and its application for a novel self-nanoemulsifying powder (SNEP) formulation analysis and dissolution study

Label claim (mg/tab)

Mean estimated amt (mg)

%Label claim ± SD

%RSD

2

1.995

99.75 ± 0.4712

0.4723

2

2.0048

100.24 ± 0.5234

0.5221

2

2.0064

100.32 ± 0.4372

0.4358